References
- 홍유라, 정석훈, 김경보, 이상호, 최경현, 박선자, 박무인, 전병찬, “Clostridium difficile B 독소 유전자 직접검출법에 의한 항생제 연관 설사증과의막성 대장염의 진단”, 감염과 화학요법, 제35권, 제5호, pp.241-248, 2003.
- http://www.ascp.org/MainMenu/NewsReleases/Ascp-Hot-Topic-Clostridium difficile.aspx
- J. Brazier, “The diagnosis of Clostridium difficile-associated disease,” Journal of Antimicrobial Chemotherapy, Vol.41, pp.29-40, 1998.
- M. Delmee, “Laboratory diagnosis of Clostridium difficile disease,” Clinical Microbiol Infect, Vol.7, pp.411-416, 2001. https://doi.org/10.1046/j.1198-743x.2001.00294.x
- 박은숙, 장경희, 윤영옥, 이정신, 김태곤, 여한승, 김선호, 신정원, 이경원, 김준명, “일개 대학병원 신경외과중환자실에서 Clostridium difficile 관련 설사 감소를 위한 CQI활동”, 한국의료QA학회지, 제8권, 제1호, pp.10-21, 2000.
- 김흥빈, 김남중, 최희정, 오명돈, 김의종, 최강원,“항생제 사용과 관련된 Clostridium difficile 감염증”, 대한화학요법학회지, 제15권, 제1호, pp.45-51, 1997.
- 김양기, 이영목, 어수택. “Rifampicin에 의한 Clostridium difficile-associated disease 1예”, 순천향의대논문집, 제10권, 제2호, pp.609-613, 2004.
- 이충렬, 이준규, 조용석, 유효민, 김원호, 이경원,“Clostridium difficile-associated disease에 대한 임상적 고찰”, 대한소화기학회지, 제33권, 제3호, pp.338-347, 1999.
- H. Kato, N. Kato, K. Watanabe, N. Iwai, H. Nakamura, T. Yamamoto, K. Suzuki, S. M. Kim, Y. Chong, and E. B. Wasito, “Identification of Toxin A-Negative, Toxin B-Positive Clostridium difficile by PCR.,”Journal of Clinical Microbiology, Vol.36, No.8, pp.2178-2182, 1998.
- D. Simon, Belanger, Boissinot M, Clairoux N, Francois J, Picard, Michel G, Bergeron. “Rapid Detection of Clostridium difficile in Feces by Real-Time PCR,” Journal of Clinical Microbiology, Vol.41, No.2, pp.730-734, 1998. https://doi.org/10.1128/JCM.41.2.730-734.2003
- H. J. Kim, T. V. Riley, M. S. Kim, C. K. Kim, D. E. Yong, K. W. Lee, Y. S. Chong, J. W. Park, “Increasing Prevalence of Toxin A-Negative, Toxin B-Positive Isolates of Clostridium difficile in korea: Impact on Laboratory Diagnosis,” Journal of Clinical Microbiology, Vol.46, No.3, pp.1116-1117, 2008. https://doi.org/10.1128/JCM.01188-07
- H. Martin, B. Willey, D. E. Low, H. R. Staempfli, A. McGeer, P. Boerlin, M. Mulvey, and J. S. Weese, “Characterization of Clostridium difficile Strains Isolated from Patients in Ontario, Canada, from 2004 to 2006,”Journal of Clinical Microbiology, Vol.46, No.9, pp.2999-3004, 2008. https://doi.org/10.1128/JCM.02437-07
- M. Rupnik, “How to detect Clostridium difficile variant strains in a routine laboratory,” Clin Microbiol Infect, Vol.7, pp.417-420, 2001. https://doi.org/10.1046/j.1198-743x.2001.00290.x
- J. Bartlett and T. Perl, “The new Clostridium difficile - What Does It Mean?,” The New England Journal of Medicine, Vol.353, No.23, pp.2503-2505, 2005. https://doi.org/10.1056/NEJMe058221
- 신보문, 유수진, 오혜전, “Clostridium difficile 독소 A 및 독소 B 검출을 위한 효소면역법의 비교.”, 대한진단검사의학회지, 제29권, 제2호, pp.122-126, 2009.
- L. V. McFarland, M. E. Mulligan, R. Y. Y. Kwork, and W. E. Stamm, “Nosocomial acquisition of Clostridium difficile infection,” N Engl J Med, Vol.320, pp.204-210, 1989. https://doi.org/10.1056/NEJM198901263200402
- A. Anand, B. Bashey, T. Mir, and A. E. Glatt, “Epidemiology, clinical manifestations, and outcome of Clostridium difficile- associated diarrhea.” Am J Gastroenterol, Vol.89, pp.519-523, 1993.
- M. Zilberberg, A. Shorr, and M. Kollef, “Increase in Adult Clostridium difficile-related Hospitalizations and Case-Fatality Rate, United States, 2000-2005,” Emerging Infectious Diseases, Vol.14, No.6, pp.929-931, 2008. https://doi.org/10.3201/eid1406.071447
- T. Wilkins and D. Lyerly, “Clostridium difficile Testing: after 20 Years, Still Challenging,”Journal of Clinical Microbiology, Vol.41, No.2, pp.531-534, 2003. https://doi.org/10.1128/JCM.41.2.531-534.2003